Impact of renin‐angiotensin system inhibitors on long‐term clinical outcomes of patients with rheumatic heart disease

AIMS: Rheumatic heart disease (RHD) remains a major global health problem. Renin–angiotensin–aldosterone system inhibitors (RAASi) are commonly administered in the treatment of cardiovascular disease, but its role in RHD patients is still limited. We performed a retrospective study to determine the...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Cheng, Lai, Yanxian, Wu, Deping, Fu, Ruibin, Li, Yanfang, Li, Hu, Guan, Tianwang, Shen, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712808/
https://www.ncbi.nlm.nih.gov/pubmed/34545695
http://dx.doi.org/10.1002/ehf2.13623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712808/
https://www.ncbi.nlm.nih.gov/pubmed/34545695
http://dx.doi.org/10.1002/ehf2.13623

Ejemplares similares